Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 120

1.

MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice.

Sastre-Garriga J, Pareto D, Battaglini M, Rocca MA, Ciccarelli O, Enzinger C, Wuerfel J, Sormani MP, Barkhof F, Yousry TA, De Stefano N, Tintoré M, Filippi M, Gasperini C, Kappos L, Río J, Frederiksen J, Palace J, Vrenken H, Montalban X, Rovira À; MAGNIMS study group.

Nat Rev Neurol. 2020 Feb 24. doi: 10.1038/s41582-020-0314-x. [Epub ahead of print] Review.

PMID:
32094485
2.

Longitudinal patterns of cortical thinning in multiple sclerosis.

Tsagkas C, Chakravarty MM, Gaetano L, Naegelin Y, Amann M, Parmar K, Papadopoulou A, Wuerfel J, Kappos L, Sprenger T, Magon S.

Hum Brain Mapp. 2020 Feb 17. doi: 10.1002/hbm.24940. [Epub ahead of print]

PMID:
32067281
3.

High-dose vitamin D supplementation in multiple sclerosis - results from the randomized EVIDIMS (efficacy of vitamin D supplementation in multiple sclerosis) trial.

Dörr J, Bäcker-Koduah P, Wernecke KD, Becker E, Hoffmann F, Faiss J, Brockmeier B, Hoffmann O, Anvari K, Wuerfel J, Piper SK, Bellmann-Strobl J, Brandt AU, Paul F.

Mult Scler J Exp Transl Clin. 2020 Jan 24;6(1):2055217320903474. doi: 10.1177/2055217320903474. eCollection 2020 Jan-Mar.

4.

Volume loss in the deep gray matter and thalamic subnuclei: a longitudinal study on disability progression in multiple sclerosis.

Magon S, Tsagkas C, Gaetano L, Patel R, Naegelin Y, Amann M, Parmar K, Papadopoulou A, Wuerfel J, Stippich C, Kappos L, Chakravarty MM, Sprenger T.

J Neurol. 2020 Feb 10. doi: 10.1007/s00415-020-09740-4. [Epub ahead of print]

PMID:
32040710
5.

New and enlarging white matter lesions adjacent to the ventricle system and thalamic atrophy are independently associated with lateral ventricular enlargement in multiple sclerosis.

Sinnecker T, Ruberte E, Schädelin S, Canova V, Amann M, Naegelin Y, Penner IK, Müller J, Kuhle J, Décard B, Derfuss T, Kappos L, Granziera C, Wuerfel J, Magon S, Yaldizli Ö.

J Neurol. 2020 Jan;267(1):192-202. doi: 10.1007/s00415-019-09565-w. Epub 2019 Oct 14.

PMID:
31612322
6.

Brain iron and metabolic abnormalities in C19orf12 mutation carriers: A 7.0 tesla MRI study in mitochondrial membrane protein-associated neurodegeneration.

Dusek P, Mekle R, Skowronska M, Acosta-Cabronero J, Huelnhagen T, Robinson SD, Schubert F, Deschauer M, Els A, Ittermann B, Schottmann G, Madai VI, Paul F, Klopstock T, Kmiec T, Niendorf T, Wuerfel J, Schneider SA.

Mov Disord. 2020 Jan;35(1):142-150. doi: 10.1002/mds.27827. Epub 2019 Sep 13.

PMID:
31518459
7.

Evaluation of the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis.

Sinnecker T, Clarke MA, Meier D, Enzinger C, Calabrese M, De Stefano N, Pitiot A, Giorgio A, Schoonheim MM, Paul F, Pawlak MA, Schmidt R, Kappos L, Montalban X, Rovira À, Evangelou N, Wuerfel J; MAGNIMS Study Group.

JAMA Neurol. 2019 Aug 19. doi: 10.1001/jamaneurol.2019.2478. [Epub ahead of print]

PMID:
31424490
8.

Accurate, rapid and reliable, fully automated MRI brainstem segmentation for application in multiple sclerosis and neurodegenerative diseases.

Sander L, Pezold S, Andermatt S, Amann M, Meier D, Wendebourg MJ, Sinnecker T, Radue EW, Naegelin Y, Granziera C, Kappos L, Wuerfel J, Cattin P, Schlaeger R; Alzheimer's Disease Neuroimaging Initiative.

Hum Brain Mapp. 2019 Oct 1;40(14):4091-4104. doi: 10.1002/hbm.24687. Epub 2019 Jun 17.

PMID:
31206931
9.

Association of brain volume loss and long-term disability outcomes in patients with multiple sclerosis treated with teriflunomide.

Sprenger T, Kappos L, Radue EW, Gaetano L, Mueller-Lenke N, Wuerfel J, Poole EM, Cavalier S.

Mult Scler. 2019 Jun 14:1352458519855722. doi: 10.1177/1352458519855722. [Epub ahead of print]

PMID:
31198103
10.

Attack-related damage of thalamic nuclei in neuromyelitis optica spectrum disorders.

Papadopoulou A, Oertel FC, Gaetano L, Kuchling J, Zimmermann H, Chien C, Siebert N, Asseyer S, Bellmann-Strobl J, Ruprecht K, Chakravarty MM, Scheel M, Magon S, Wuerfel J, Paul F, Brandt AU.

J Neurol Neurosurg Psychiatry. 2019 Oct;90(10):1156-1164. doi: 10.1136/jnnp-2018-320249. Epub 2019 May 24.

PMID:
31127016
11.

Automated segmentation of changes in FLAIR-hyperintense white matter lesions in multiple sclerosis on serial magnetic resonance imaging.

Schmidt P, Pongratz V, Küster P, Meier D, Wuerfel J, Lukas C, Bellenberg B, Zipp F, Groppa S, Sämann PG, Weber F, Gaser C, Franke T, Bussas M, Kirschke J, Zimmer C, Hemmer B, Mühlau M.

Neuroimage Clin. 2019;23:101849. doi: 10.1016/j.nicl.2019.101849. Epub 2019 May 2.

12.

MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis.

Uccelli A, Laroni A, Brundin L, Clanet M, Fernandez O, Nabavi SM, Muraro PA, Oliveri RS, Radue EW, Sellner J, Soelberg Sorensen P, Sormani MP, Wuerfel JT, Battaglia MA, Freedman MS; MESEMS study group.

Trials. 2019 May 9;20(1):263. doi: 10.1186/s13063-019-3346-z.

13.

Diagnosis of adult-onset MELAS syndrome in a 63-year-old patient with suspected recurrent strokes - a case report.

Sinnecker T, Andelova M, Mayr M, Rüegg S, Sinnreich M, Hench J, Frank S, Schaller A, Stippich C, Wuerfel J, Bonati LH.

BMC Neurol. 2019 May 8;19(1):91. doi: 10.1186/s12883-019-1306-6.

14.

Quantitative 7T MRI does not detect occult brain damage in neuromyelitis optica.

Pasquier B, Borisow N, Rasche L, Bellmann-Strobl J, Ruprecht K, Niendorf T, Derfuss TJ, Wuerfel J, Paul F, Sinnecker T.

Neurol Neuroimmunol Neuroinflamm. 2019 Mar 7;6(3):e541. doi: 10.1212/NXI.0000000000000541. eCollection 2019 May.

15.

Relationships of Overt and Silent Brain Lesions With Cognitive Function in Patients With Atrial Fibrillation.

Conen D, Rodondi N, Müller A, Beer JH, Ammann P, Moschovitis G, Auricchio A, Hayoz D, Kobza R, Shah D, Novak J, Schläpfer J, Di Valentino M, Aeschbacher S, Blum S, Meyre P, Sticherling C, Bonati LH, Ehret G, Moutzouri E, Fischer U, Monsch AU, Stippich C, Wuerfel J, Sinnecker T, Coslovsky M, Schwenkglenks M, Kühne M, Osswald S; Swiss-AF Study Investigators.

J Am Coll Cardiol. 2019 Mar 12;73(9):989-999. doi: 10.1016/j.jacc.2018.12.039.

PMID:
30846109
16.

Leptomeningeal and Intraparenchymal Blood Barrier Disruption in a MOG-IgG-Positive Patient.

Mohseni SH, Skejoe HPB, Wuerfel J, Paul F, Reindl M, Jarius S, Asgari N.

Case Rep Neurol Med. 2018 Dec 9;2018:1365175. doi: 10.1155/2018/1365175. eCollection 2018.

17.

Clinical associations of T2-weighted lesion load and lesion location in small vessel disease: Insights from a large prospective cohort study.

Altermatt A, Gaetano L, Magon S, Bauer L, Feurer R, Gnahn H, Hartmann J, Seifert CL, Poppert H, Wuerfel J, Radue EW, Kappos L, Sprenger T.

Neuroimage. 2019 Apr 1;189:727-733. doi: 10.1016/j.neuroimage.2019.01.052. Epub 2019 Jan 24.

PMID:
30685330
18.

Central Slab versus Whole Brain to Measure Brain Atrophy in Multiple Sclerosis.

Ruberte E, Sinnecker T, Amann M, Gaetano L, Naegelin Y, Penner IK, Kuhle J, Derfuss T, Kappos L, Granziera C, Wuerfel J, Yaldizli Ö.

Eur Neurol. 2018;80(3-4):207-214. doi: 10.1159/000495798. Epub 2019 Jan 3.

PMID:
30605898
19.

The choice of embedding media affects image quality, tissue R2 * , and susceptibility behaviors in post-mortem brain MR microscopy at 7.0T.

Dusek P, Madai VI, Huelnhagen T, Bahn E, Matej R, Sobesky J, Niendorf T, Acosta-Cabronero J, Wuerfel J.

Magn Reson Med. 2019 Apr;81(4):2688-2701. doi: 10.1002/mrm.27595. Epub 2018 Dec 2.

PMID:
30506939
20.

Design and construction of an innovative brain phantom prototype for MRI.

Altermatt A, Santini F, Deligianni X, Magon S, Sprenger T, Kappos L, Cattin P, Wuerfel J, Gaetano L.

Magn Reson Med. 2019 Feb;81(2):1165-1171. doi: 10.1002/mrm.27464. Epub 2018 Sep 17.

PMID:
30221790
21.

Longitudinal study of multiple sclerosis lesions using ultra-high field (7T) multiparametric MR imaging.

Chawla S, Kister I, Sinnecker T, Wuerfel J, Brisset JC, Paul F, Ge Y.

PLoS One. 2018 Sep 13;13(9):e0202918. doi: 10.1371/journal.pone.0202918. eCollection 2018.

22.

A comparison of brain magnetic resonance imaging lesions in multiple sclerosis by race with reference to disability progression.

Nakamura Y, Gaetano L, Matsushita T, Anna A, Sprenger T, Radue EW, Wuerfel J, Bauer L, Amann M, Shinoda K, Isobe N, Yamasaki R, Saida T, Kappos L, Kira JI.

J Neuroinflammation. 2018 Sep 5;15(1):255. doi: 10.1186/s12974-018-1295-1.

23.

MRI-based prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis using SVM and lesion geometry.

Bendfeldt K, Taschler B, Gaetano L, Madoerin P, Kuster P, Mueller-Lenke N, Amann M, Vrenken H, Wottschel V, Barkhof F, Borgwardt S, Klöppel S, Wicklein EM, Kappos L, Edan G, Freedman MS, Montalbán X, Hartung HP, Pohl C, Sandbrink R, Sprenger T, Radue EW, Wuerfel J, Nichols TE.

Brain Imaging Behav. 2019 Oct;13(5):1361-1374. doi: 10.1007/s11682-018-9942-9.

PMID:
30155789
24.

7 Tesla MRI of Balo's concentric sclerosis versus multiple sclerosis lesions.

Behrens JR, Wanner J, Kuchling J, Ostendorf L, Harms L, Ruprecht K, Niendorf T, Jarius S, Wildemann B, Gieß RM, Scheel M, Bellmann-Strobl J, Wuerfel J, Paul F, Sinnecker T.

Ann Clin Transl Neurol. 2018 Jun 29;5(8):900-912. doi: 10.1002/acn3.572. eCollection 2018 Aug.

25.

Spinal cord volume loss: A marker of disease progression in multiple sclerosis.

Tsagkas C, Magon S, Gaetano L, Pezold S, Naegelin Y, Amann M, Stippich C, Cattin P, Wuerfel J, Bieri O, Sprenger T, Kappos L, Parmar K.

Neurology. 2018 Jul 24;91(4):e349-e358. doi: 10.1212/WNL.0000000000005853. Epub 2018 Jun 27.

PMID:
29950437
26.

Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis.

Barro C, Benkert P, Disanto G, Tsagkas C, Amann M, Naegelin Y, Leppert D, Gobbi C, Granziera C, Yaldizli Ö, Michalak Z, Wuerfel J, Kappos L, Parmar K, Kuhle J.

Brain. 2018 Aug 1;141(8):2382-2391. doi: 10.1093/brain/awy154.

PMID:
29860296
27.

Clinical Correlations of Brain Lesion Location in Multiple Sclerosis: Voxel-Based Analysis of a Large Clinical Trial Dataset.

Altermatt A, Gaetano L, Magon S, Häring DA, Tomic D, Wuerfel J, Radue EW, Kappos L, Sprenger T.

Brain Topogr. 2018 Sep;31(5):886-894. doi: 10.1007/s10548-018-0652-9. Epub 2018 May 29.

PMID:
29845492
28.

Preferential spinal cord volume loss in primary progressive multiple sclerosis.

Tsagkas C, Magon S, Gaetano L, Pezold S, Naegelin Y, Amann M, Stippich C, Cattin P, Wuerfel J, Bieri O, Sprenger T, Kappos L, Parmar K.

Mult Scler. 2019 Jun;25(7):947-957. doi: 10.1177/1352458518775006. Epub 2018 May 21.

PMID:
29781383
29.

Reliable and fast volumetry of the lumbar spinal cord using cord image analyser (Cordial).

Tsagkas C, Altermatt A, Bonati U, Pezold S, Reinhard J, Amann M, Cattin P, Wuerfel J, Fischer D, Parmar K, Fischmann A.

Eur Radiol. 2018 Nov;28(11):4488-4495. doi: 10.1007/s00330-018-5431-1. Epub 2018 Apr 30.

PMID:
29713776
30.

Future Brain and Spinal Cord Volumetric Imaging in the Clinic for Monitoring Treatment Response in MS.

Sinnecker T, Granziera C, Wuerfel J, Schlaeger R.

Curr Treat Options Neurol. 2018 Apr 20;20(6):17. doi: 10.1007/s11940-018-0504-7. Review.

PMID:
29679165
31.

The role of the cerebellum in multiple sclerosis-150 years after Charcot.

Parmar K, Stadelmann C, Rocca MA, Langdon D, D'Angelo E, D'Souza M, Burggraaff J, Wegner C, Sastre-Garriga J, Barrantes-Freer A, Dorn J, Uitdehaag BMJ, Montalban X, Wuerfel J, Enzinger C, Rovira A, Tintore M, Filippi M, Kappos L, Sprenger T; MAGNIMS study group.

Neurosci Biobehav Rev. 2018 Jun;89:85-98. doi: 10.1016/j.neubiorev.2018.02.012. Epub 2018 Feb 23. Review.

PMID:
29477616
32.

Impact of 3 Tesla MRI on interobserver agreement in clinically isolated syndrome: A MAGNIMS multicentre study.

Hagens MH, Burggraaff J, Kilsdonk ID, Ruggieri S, Collorone S, Cortese R, Cawley N, Sbardella E, Andelova M, Amann M, Lieb JM, Pantano P, Lissenberg-Witte BI, Killestein J, Oreja-Guevara C, Wuerfel J, Ciccarelli O, Gasperini C, Lukas C, Rovira A, Barkhof F, Wattjes MP; MAGNIMS Study Group.

Mult Scler. 2019 Mar;25(3):352-360. doi: 10.1177/1352458517751647. Epub 2018 Jan 12.

33.

Teriflunomide slows BVL in relapsing MS: A reanalysis of the TEMSO MRI data set using SIENA.

Radue EW, Sprenger T, Gaetano L, Mueller-Lenke N, Cavalier S, Thangavelu K, Panzara MA, Donaldson JE, Woodward FM, Wuerfel J, Wolinsky JS, Kappos L.

Neurol Neuroimmunol Neuroinflamm. 2017 Aug 9;4(5):e390. doi: 10.1212/NXI.0000000000000390. eCollection 2017 Sep.

34.

Design of the Swiss Atrial Fibrillation Cohort Study (Swiss-AF): structural brain damage and cognitive decline among patients with atrial fibrillation.

Conen D, Rodondi N, Mueller A, Beer J, Auricchio A, Ammann P, Hayoz D, Kobza R, Moschovitis G, Shah D, Schlaepfer J, Novak J, di Valentino M, Erne P, Sticherling C, Bonati L, Ehret G, Roten L, Fischer U, Monsch A, Stippich C, Wuerfel J, Schwenkglenks M, Kuehne M, Osswald S.

Swiss Med Wkly. 2017 Jul 10;147:w14467. doi: 10.4414/smw.2017.14467. eCollection 2017.

35.

Disruption of the leptomeningeal blood barrier in neuromyelitis optica spectrum disorder.

Asgari N, Flanagan EP, Fujihara K, Kim HJ, Skejoe HP, Wuerfel J, Kuroda H, Kim SH, Maillart E, Marignier R, Pittock SJ, Paul F, Weinshenker BG.

Neurol Neuroimmunol Neuroinflamm. 2017 Apr 21;4(4):e343. doi: 10.1212/NXI.0000000000000343. eCollection 2017 Jul.

36.

Epstein-Barr virus antibodies in serum and DNA load in saliva are not associated with radiological or clinical disease activity in patients with early multiple sclerosis.

Gieß RM, Pfuhl C, Behrens JR, Rasche L, Freitag E, Khalighy N, Otto C, Wuerfel J, Brandt AU, Hofmann J, Eberspächer B, Bellmann-Strobl J, Paul F, Ruprecht K.

PLoS One. 2017 Apr 7;12(4):e0175279. doi: 10.1371/journal.pone.0175279. eCollection 2017.

37.

Brain iron accumulation in Wilson's disease: A longitudinal imaging case study during anticopper treatment using 7.0T MRI and transcranial sonography.

Dusek P, Skoloudik D, Maskova J, Huelnhagen T, Bruha R, Zahorakova D, Niendorf T, Ruzicka E, Schneider SA, Wuerfel J.

J Magn Reson Imaging. 2018 Jan;47(1):282-285. doi: 10.1002/jmri.25702. Epub 2017 Apr 4.

PMID:
28376267
38.

Inflammation-induced brain endothelial activation leads to uptake of electrostatically stabilized iron oxide nanoparticles via sulfated glycosaminoglycans.

Berndt D, Millward JM, Schnorr J, Taupitz M, Stangl V, Paul F, Wagner S, Wuerfel JT, Sack I, Ludwig A, Infante-Duarte C.

Nanomedicine. 2017 May;13(4):1411-1421. doi: 10.1016/j.nano.2017.01.010. Epub 2017 Jan 25.

PMID:
28131884
39.

Progressive Multifocal Leukoencephalopathy in a Multiple Sclerosis Patient Diagnosed after Switching from Natalizumab to Fingolimod.

Sinnecker T, Othman J, Kühl M, Metz I, Niendorf T, Kunkel A, Paul F, Wuerfel J, Faiss J.

Case Rep Neurol Med. 2016;2016:5876798. Epub 2016 Nov 22.

40.

The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative.

Sati P, Oh J, Constable RT, Evangelou N, Guttmann CR, Henry RG, Klawiter EC, Mainero C, Massacesi L, McFarland H, Nelson F, Ontaneda D, Rauscher A, Rooney WD, Samaraweera AP, Shinohara RT, Sobel RA, Solomon AJ, Treaba CA, Wuerfel J, Zivadinov R, Sicotte NL, Pelletier D, Reich DS; NAIMS Cooperative.

Nat Rev Neurol. 2016 Dec;12(12):714-722. doi: 10.1038/nrneurol.2016.166. Epub 2016 Nov 11. Review.

PMID:
27834394
41.

Gadopentetate but not gadobutrol accumulates in the dentate nucleus of multiple sclerosis patients.

Schlemm L, Chien C, Bellmann-Strobl J, Dörr J, Wuerfel J, Brandt AU, Paul F, Scheel M.

Mult Scler. 2017 Jun;23(7):963-972. doi: 10.1177/1352458516670738. Epub 2016 Sep 27.

PMID:
27679460
42.

Multifrequency magnetic resonance elastography of the brain reveals tissue degeneration in neuromyelitis optica spectrum disorder.

Streitberger KJ, Fehlner A, Pache F, Lacheta A, Papazoglou S, Bellmann-Strobl J, Ruprecht K, Brandt A, Braun J, Sack I, Paul F, Wuerfel J.

Eur Radiol. 2017 May;27(5):2206-2215. doi: 10.1007/s00330-016-4561-6. Epub 2016 Aug 29.

PMID:
27572811
43.

Brain iron accumulation in Wilson disease: a post mortem 7 Tesla MRI - histopathological study.

Dusek P, Bahn E, Litwin T, Jabłonka-Salach K, Łuciuk A, Huelnhagen T, Madai VI, Dieringer MA, Bulska E, Knauth M, Niendorf T, Sobesky J, Paul F, Schneider SA, Czlonkowska A, Brück W, Wegner C, Wuerfel J.

Neuropathol Appl Neurobiol. 2017 Oct;43(6):514-532. doi: 10.1111/nan.12341. Epub 2016 Oct 4.

PMID:
27543917
44.

MRI phase changes in multiple sclerosis vs neuromyelitis optica lesions at 7T.

Sinnecker T, Schumacher S, Mueller K, Pache F, Dusek P, Harms L, Ruprecht K, Nytrova P, Chawla S, Niendorf T, Kister I, Paul F, Ge Y, Wuerfel J.

Neurol Neuroimmunol Neuroinflamm. 2016 Jul 22;3(4):e259. doi: 10.1212/NXI.0000000000000259. eCollection 2016 Aug.

45.

Design of TRUST, a non-interventional, multicenter, 3-year prospective study investigating an integrated patient management approach in patients with relapsing-remitting multiple sclerosis treated with natalizumab.

Ziemssen T, Gass A, Wuerfel J, Bayas A, Tackenberg B, Limmroth V, Linker R, Mäurer M, Haas J, Stangel M, Meergans M, Harlin O, Hartung HP.

BMC Neurol. 2016 Jul 12;16:98. doi: 10.1186/s12883-016-0625-0.

46.

Neuromyelitis optica does not impact periventricular venous density versus healthy controls: a 7.0 Tesla MRI clinical study.

Schumacher S, Pache F, Bellmann-Strobl J, Behrens J, Dusek P, Harms L, Ruprecht K, Nytrova P, Chawla S, Niendorf T, Kister I, Paul F, Ge Y, Wuerfel J, Sinnecker T.

MAGMA. 2016 Jun;29(3):535-41. doi: 10.1007/s10334-016-0554-3. Epub 2016 Apr 12.

PMID:
27072685
47.

Moyamoya Vessel Pathology Imaged by Ultra-High-Field Magnetic Resonance Imaging at 7.0 T.

Dengler NF, Madai VI, Wuerfel J, von Samson-Himmelstjerna FC, Dusek P, Niendorf T, Sobesky J, Vajkoczy P.

J Stroke Cerebrovasc Dis. 2016 Jun;25(6):1544-51. doi: 10.1016/j.jstrokecerebrovasdis.2016.01.041. Epub 2016 Apr 1.

PMID:
27053027
48.

Power estimation for non-standardized multisite studies.

Keshavan A, Paul F, Beyer MK, Zhu AH, Papinutto N, Shinohara RT, Stern W, Amann M, Bakshi R, Bischof A, Carriero A, Comabella M, Crane JC, D'Alfonso S, Demaerel P, Dubois B, Filippi M, Fleischer V, Fontaine B, Gaetano L, Goris A, Graetz C, Gröger A, Groppa S, Hafler DA, Harbo HF, Hemmer B, Jordan K, Kappos L, Kirkish G, Llufriu S, Magon S, Martinelli-Boneschi F, McCauley JL, Montalban X, Mühlau M, Pelletier D, Pattany PM, Pericak-Vance M, Cournu-Rebeix I, Rocca MA, Rovira A, Schlaeger R, Saiz A, Sprenger T, Stecco A, Uitdehaag BMJ, Villoslada P, Wattjes MP, Weiner H, Wuerfel J, Zimmer C, Zipp F; International Multiple Sclerosis Genetics Consortium. Electronic address: AIVINSON@PARTNERS.ORG, Hauser SL, Oksenberg JR, Henry RG.

Neuroimage. 2016 Jul 1;134:281-294. doi: 10.1016/j.neuroimage.2016.03.051. Epub 2016 Apr 1.

49.

Brain parenchymal damage in neuromyelitis optica spectrum disorder - A multimodal MRI study.

Pache F, Zimmermann H, Finke C, Lacheta A, Papazoglou S, Kuchling J, Wuerfel J, Hamm B, Ruprecht K, Paul F, Brandt AU, Scheel M.

Eur Radiol. 2016 Dec;26(12):4413-4422. Epub 2016 Mar 24.

PMID:
27012555
50.

Iron and Non-Iron-Related Characteristics of Multiple Sclerosis and Neuromyelitis Optica Lesions at 7T MRI.

Chawla S, Kister I, Wuerfel J, Brisset JC, Liu S, Sinnecker T, Dusek P, Haacke EM, Paul F, Ge Y.

AJNR Am J Neuroradiol. 2016 Jul;37(7):1223-30. doi: 10.3174/ajnr.A4729. Epub 2016 Mar 24.

Supplemental Content

Loading ...
Support Center